These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 488407)

  • 1. New therapeutic approach to the hirsute patient.
    Boisselle A; Tremblay RR
    Fertil Steril; 1979 Sep; 32(3):276-9. PubMed ID: 488407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone in the treatment of hirsutism.
    Köksal A; Pabuçcu R; Akyürek C
    Arch Gynecol; 1987; 240(2):95-100. PubMed ID: 3105474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of spironolactone on hirsutism and female androgen metabolism.
    Dorrington-Ward P; McCartney AC; Holland S; Scully J; Carter G; Alaghband-Zadeh J; Wise P
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):161-7. PubMed ID: 4053414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-effects of spironolactone therapy in the hirsute woman.
    Helfer EL; Miller JL; Rose LI
    J Clin Endocrinol Metab; 1988 Jan; 66(1):208-11. PubMed ID: 3335604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone, 17 Ks, 17 beta E2 FSH-LH variations and hirsutism modifications during spironolactone therapy.
    Spandri P; Gangemi M; Nardelli GB; Meneghetti G; Grandesso R; De Salvia D; Ambrosio GB; Predebon O
    Clin Exp Obstet Gynecol; 1984; 11(1-2):49-54. PubMed ID: 6424970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel use of spironolactone: treatment of hirsutism.
    Shapiro G; Evron S
    J Clin Endocrinol Metab; 1980 Sep; 51(3):429-32. PubMed ID: 7410528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of spironolactone on hair shaft diameter in hirsute females.
    McLellan AR; Rentoul J; MacKie R; McInnes GT
    Postgrad Med J; 1989 Jul; 65(765):459-62. PubMed ID: 2690044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women.
    Lobo RA; Shoupe D; Serafini P; Brinton D; Horton R
    Fertil Steril; 1985 Feb; 43(2):200-5. PubMed ID: 3967781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spironolactone is an effective and well tolerated systemic antiandrogen therapy for Hirsute women.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    J Clin Endocrinol Metab; 1989 May; 68(5):966-70. PubMed ID: 2715294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of hirsutism in adolescent girls with spironolactone].
    Malinova M
    Akush Ginekol (Sofiia); 1999; 38(4):28-30. PubMed ID: 10726349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of spironolactone in treatment of hirsutism.
    Cumming DC
    Cleve Clin J Med; 1990 May; 57(3):285-7. PubMed ID: 2357784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
    O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
    J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose spironolactone in the treatment of female hirsutism.
    Ylöstalo P; Heikkinen J; Kauppila A; Pakarinen A; Järvinen PA
    Int J Fertil; 1987; 32(1):41-5. PubMed ID: 2880814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone in the treatment of hirsutism.
    Anttila L; Ruutiainen K; Erkkola R
    Ann Chir Gynaecol Suppl; 1987; 202():32-4. PubMed ID: 3310825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
    Wong IL; Morris RS; Chang L; Spahn MA; Stanczyk FZ; Lobo RA
    J Clin Endocrinol Metab; 1995 Jan; 80(1):233-8. PubMed ID: 7829618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
    Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
    J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hirsutism with spironolactone.
    Tremblay RR
    Clin Endocrinol Metab; 1986 May; 15(2):363-71. PubMed ID: 2941190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.
    Azziz R; Ochoa TM; Bradley EL; Potter HD; Boots LR
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3406-11. PubMed ID: 8530573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of spironolactone in dermatology.
    Rathnayake D; Sinclair R
    Skinmed; 2010; 8(6):328-32; quiz 333. PubMed ID: 21413648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.